Agilent Technologies (China) Co., Ltd.
Agilent Technology (China) Co., Ltd. is affiliated to Agilent Technology Co., Ltd. (NYSE: A). Agilent Technology Co., Ltd. (NYSE: A) is a global pioneer in the life sciences, diagnostics and applied chemistry markets, focusing on six key areas: food, environment and forensics, drugs, diagnosis, chemicals and energy, and research. Committed to providing keen insights and innovative experiences to improve the quality of human life. Agilent’s instruments, software, services, solutions and experts can provide more reliable answers to customers’ challenging problems. Headquartered in Santa Clara, California, Agilent Company provides instruments, services, consumables, applications and expertise to laboratories in more than 100 countries and regions around the world. Agilent is also a high-tech enterprise that entered the Chinese market earlier after the reform and opening up. Agilent entered China in the 1980s. For many years, Agilent has always adhered to the development strategy of "in China, for China" and is highly consistent with China's macro-development strategy. Agilent's China headquarters is located in Beijing, with factories and R&D centers in Shanghai and Hangzhou respectively, and has subsidiaries and offices in many cities in China. The business involves product research and development and manufacturing, marketing, sales, and after-sales service support. The company provides instruments, services, consumables, applications and expertise to laboratories around the world to help customers get the insight they seek. Agilent’s expertise and trusted collaboration enable customers to be confident in the solutions we provide.
Agilent Technologies (China) Co., Ltd.
Agilent Technology (China) Co., Ltd. is affiliated to Agilent Technology Co., Ltd. (NYSE: A). Agilent Technology Co., Ltd. (NYSE: A) is a global pioneer in the life sciences, diagnostics and applied chemistry markets, focusing on six key areas: food, environment and forensics, drugs, diagnosis, chemicals and energy, and research. Committed to providing keen insights and innovative experiences to improve the quality of human life. Agilent’s instruments, software, services, solutions and experts can provide more reliable answers to customers’ challenging problems. Headquartered in Santa Clara, California, Agilent Company provides instruments, services, consumables, applications and expertise to laboratories in more than 100 countries and regions around the world. Agilent is also a high-tech enterprise that entered the Chinese market earlier after the reform and opening up. Agilent entered China in the 1980s. For many years, Agilent has always adhered to the development strategy of "in China, for China" and is highly consistent with China's macro-development strategy. Agilent's China headquarters is located in Beijing, with factories and R&D centers in Shanghai and Hangzhou respectively, and has subsidiaries and offices in many cities in China. The business involves product research and development and manufacturing, marketing, sales, and after-sales service support. The company provides instruments, services, consumables, applications and expertise to laboratories around the world to help customers get the insight they seek. Agilent’s expertise and trusted collaboration enable customers to be confident in the solutions we provide.
Beckman Coulter Trading (China) Co., Ltd.
Beckman Coulter was formed by the merger of Beckman Instruments, founded by Dr. Beckman and Kurt Electronic Instruments, founded by the Kurt brothers. Headquartered in Brea, California, USA, as one of the global leaders in in vitro diagnosis, Beckman Coulter shoulders the mission of "incessant medical exploration and wholehearted diagnosis", and perseveres in exploring breakthroughs and innovations in testing technology, and devotes itself to all over the world. Medical institutions and laboratories provide innovative and intelligent diagnostic solutions. As one of the first international in vitro diagnostic companies to enter the Chinese market, Beckman Coulter began setting up representative offices and repair stations in many places in China 40 years ago. Since the Suzhou Reagent Factory was completed in 1997, Beckman Coulter started the chapter of localized production. In 2011, he officially joined the Danaher Group. Under the guidance of the Danaher's "Creating China" strategy, he continued to increase investment in local production, local R&D and innovation and local cooperation to meet the diversity needs of Chinese customers. In 2023, the China R&D and manufacturing base of the Danaher Diagnostic Platform will be officially put into use. As an important operating company, Beckman Coulter's local production and R&D capabilities will be comprehensively improved. At present, China's "intelligent" manufacturing of all major equipment has been achieved, and in the future, the comprehensive domestic production of all products will be accelerated. Beckman Coulter Diagnostics is proud to be a member of Danaher. Danaher's leading position in technology has put Beckman Coulter Diagnostics' solutions at the forefront of the industry and benefit more people. Being a member of Danaher means providing customers with extensive and in-depth expertise and solutions.
Beckman Coulter Trading (China) Co., Ltd.
Beckman Coulter was formed by the merger of Beckman Instruments, founded by Dr. Beckman and Kurt Electronic Instruments, founded by the Kurt brothers. Headquartered in Brea, California, USA, as one of the global leaders in in vitro diagnosis, Beckman Coulter shoulders the mission of "incessant medical exploration and wholehearted diagnosis", and perseveres in exploring breakthroughs and innovations in testing technology, and devotes itself to all over the world. Medical institutions and laboratories provide innovative and intelligent diagnostic solutions. As one of the first international in vitro diagnostic companies to enter the Chinese market, Beckman Coulter began setting up representative offices and repair stations in many places in China 40 years ago. Since the Suzhou Reagent Factory was completed in 1997, Beckman Coulter started the chapter of localized production. In 2011, he officially joined the Danaher Group. Under the guidance of the Danaher's "Creating China" strategy, he continued to increase investment in local production, local R&D and innovation and local cooperation to meet the diversity needs of Chinese customers. In 2023, the China R&D and manufacturing base of the Danaher Diagnostic Platform will be officially put into use. As an important operating company, Beckman Coulter's local production and R&D capabilities will be comprehensively improved. At present, China's "intelligent" manufacturing of all major equipment has been achieved, and in the future, the comprehensive domestic production of all products will be accelerated. Beckman Coulter Diagnostics is proud to be a member of Danaher. Danaher's leading position in technology has put Beckman Coulter Diagnostics' solutions at the forefront of the industry and benefit more people. Being a member of Danaher means providing customers with extensive and in-depth expertise and solutions.
Tecan (Shanghai) Laboratory Equipment Co., Ltd.
TECAN Switzerland is a global provider of advanced automation and solutions for life sciences and biopharmaceuticals, forensics and clinical diagnosis. The company was founded in 1980 and is headquartered in Switzerland. It has its own R&D and production bases in Switzerland, North America and Austria respectively. Currently, the company's main products are three categories: fully automated liquid treatment platform (Liquid Handling & Robotics), Multimode Reader and OEM components; sales service network is spread across 52 countries around the world, with customers covering pharmaceutical companies, biotechnology companies, research institutes, forensics, hospitals, blood station systems, entry and exit inspection and quarantine (CIQ) and the Centers for Disease Control (CDC), etc. Its liquid treatment technology has 32 years of industry experience, is at an advanced level around the world, and is favored by professional life science laboratories in the world. As an original equipment OEM manufacturer, TECAN also occupies an important position in the development and production of OEM equipment and components. In 2011, TECAN CHF 377 million (i.e., US$424 million; or €306 million) sales results were generated. TECAN , China and Switzerland, opened a representative office in Beijing in 2004 and officially entered the Chinese market. In April 2008, Diken (Shanghai) Trading Co., Ltd. was established in Pudong, Shanghai as TECAN The Group is fully responsible for TECAN in the Asia-Pacific region (except Japan and South Korea) All the Group's business activities in China include sales, marketing activities and cooperation, and customer support. Diken (Shanghai) currently has a professional pre-sales and after-sales service team, and has built a good distribution and after-sales service network in the fields of scientific research, pharmaceuticals, public security criminal investigation, hospitals, blood stations, CDC and CIQ, and strives to compare The service concept of customers expecting to do better" provides professional services to the majority of end users.
Tecan (Shanghai) Laboratory Equipment Co., Ltd.
TECAN Switzerland is a global provider of advanced automation and solutions for life sciences and biopharmaceuticals, forensics and clinical diagnosis. The company was founded in 1980 and is headquartered in Switzerland. It has its own R&D and production bases in Switzerland, North America and Austria respectively. Currently, the company's main products are three categories: fully automated liquid treatment platform (Liquid Handling & Robotics), Multimode Reader and OEM components; sales service network is spread across 52 countries around the world, with customers covering pharmaceutical companies, biotechnology companies, research institutes, forensics, hospitals, blood station systems, entry and exit inspection and quarantine (CIQ) and the Centers for Disease Control (CDC), etc. Its liquid treatment technology has 32 years of industry experience, is at an advanced level around the world, and is favored by professional life science laboratories in the world. As an original equipment OEM manufacturer, TECAN also occupies an important position in the development and production of OEM equipment and components. In 2011, TECAN CHF 377 million (i.e., US$424 million; or €306 million) sales results were generated. TECAN , China and Switzerland, opened a representative office in Beijing in 2004 and officially entered the Chinese market. In April 2008, Diken (Shanghai) Trading Co., Ltd. was established in Pudong, Shanghai as TECAN The Group is fully responsible for TECAN in the Asia-Pacific region (except Japan and South Korea) All the Group's business activities in China include sales, marketing activities and cooperation, and customer support. Diken (Shanghai) currently has a professional pre-sales and after-sales service team, and has built a good distribution and after-sales service network in the fields of scientific research, pharmaceuticals, public security criminal investigation, hospitals, blood stations, CDC and CIQ, and strives to compare The service concept of customers expecting to do better" provides professional services to the majority of end users.
Bole Life Medical Products (Shanghai) Co., Ltd.
Bio-Rad is in a high position in developing, manufacturing and selling a variety of innovative products for the life science research and clinical diagnosis markets. For more than 65 years, the company's products have promoted scientific discoveries and improved healthcare. Clients include universities and research institutions, hospitals, public health and commercial laboratories, and biotechnology, pharmaceutical and application research laboratories, including food safety and environmental quality. Life Science Research Products Bio-Rad is one of the world's well-known life science companies that provide instruments, software, consumables, reagents and related content for cell biology, gene expression, protein purification, protein quantification, drug discovery and production, food safety and science education. . Our products and solutions are based on technologies for isolating, purifying, identifying, analyzing, and amplifying biological materials such as antibodies, proteins, nucleic acids, cells and bacteria. Clinical diagnostic products As a well-known supplier of in vitro diagnostic supplies, the company's diagnostic products and systems utilize various technologies and provide valuable clinical information for the blood transfusion, diabetes monitoring, autoimmune and infectious disease testing markets. These products are used to support the diagnosis, monitoring and treatment of diseases and other medical conditions. Digital Biology The unique micro droplet digitalization technology has unparalleled accuracy and absolute quantitative analysis of target DNA or RNA molecules, dispersing the samples into tens of thousands of independent micro droplet systems, thus providing life science research, clinical diagnosis, environmental monitoring and food safety. Testing provides extremely sensitive and accurate digital answers.
Bole Life Medical Products (Shanghai) Co., Ltd.
Bio-Rad is in a high position in developing, manufacturing and selling a variety of innovative products for the life science research and clinical diagnosis markets. For more than 65 years, the company's products have promoted scientific discoveries and improved healthcare. Clients include universities and research institutions, hospitals, public health and commercial laboratories, and biotechnology, pharmaceutical and application research laboratories, including food safety and environmental quality. Life Science Research Products Bio-Rad is one of the world's well-known life science companies that provide instruments, software, consumables, reagents and related content for cell biology, gene expression, protein purification, protein quantification, drug discovery and production, food safety and science education. . Our products and solutions are based on technologies for isolating, purifying, identifying, analyzing, and amplifying biological materials such as antibodies, proteins, nucleic acids, cells and bacteria. Clinical diagnostic products As a well-known supplier of in vitro diagnostic supplies, the company's diagnostic products and systems utilize various technologies and provide valuable clinical information for the blood transfusion, diabetes monitoring, autoimmune and infectious disease testing markets. These products are used to support the diagnosis, monitoring and treatment of diseases and other medical conditions. Digital Biology The unique micro droplet digitalization technology has unparalleled accuracy and absolute quantitative analysis of target DNA or RNA molecules, dispersing the samples into tens of thousands of independent micro droplet systems, thus providing life science research, clinical diagnosis, environmental monitoring and food safety. Testing provides extremely sensitive and accurate digital answers.
Shanghai Flash Spectrum Biotechnology Co., Ltd.
Shanghai Flashpoint Biotechnology Co., Ltd. is a domestic high-quality grating full-wavelength microplate reader manufacturer. It was established at the Shanghai Bioengineering Center of the Chinese Academy of Sciences, focusing on the research, development, production and sales of grating full-wavelength microplate reader. Shanghai Flashlight Company's full-wavelength microplate reader product was officially launched on March 1, 2012, and has since broken the monopoly of imported products on full-wavelength microplate reader. Shanghai Shanpu Biotechnology Co., Ltd. is a professional and technical company with marketing, R&D, production and after-sales service departments. It has a scientific and technological team mainly composed of professional and technical personnel from Shanghai Jiaotong University and Shanghai Bioengineering Center of the Chinese Academy of Sciences. It has a large number of scientific and technological teams. Technical reserves and investments from famous analytical instrument companies, they are willing to provide users with high-quality products and services.
Shanghai Flash Spectrum Biotechnology Co., Ltd.
Shanghai Flashpoint Biotechnology Co., Ltd. is a domestic high-quality grating full-wavelength microplate reader manufacturer. It was established at the Shanghai Bioengineering Center of the Chinese Academy of Sciences, focusing on the research, development, production and sales of grating full-wavelength microplate reader. Shanghai Flashlight Company's full-wavelength microplate reader product was officially launched on March 1, 2012, and has since broken the monopoly of imported products on full-wavelength microplate reader. Shanghai Shanpu Biotechnology Co., Ltd. is a professional and technical company with marketing, R&D, production and after-sales service departments. It has a scientific and technological team mainly composed of professional and technical personnel from Shanghai Jiaotong University and Shanghai Bioengineering Center of the Chinese Academy of Sciences. It has a large number of scientific and technological teams. Technical reserves and investments from famous analytical instrument companies, they are willing to provide users with high-quality products and services.
Zhengzhou Antu Bioengineering Co., Ltd.
Zhengzhou Antu Bioengineering Co., Ltd. (hereinafter referred to as "Antu Biotechnology", stock code 603658) was founded in 1998. It focuses on the research, manufacturing, integration and services of in vitro diagnostic reagents and instruments. Its products cover immunity, microbial, biochemistry, and molecular , coagulation and other testing fields can provide medical laboratories with complete product solutions and overall services. The company was listed on September 1, 2016. It is an in vitro diagnostic research and development and manufacturing enterprise listed on the main board of the Shanghai Stock Exchange. It has been approved as a National Enterprise Technology Center, a National Engineering Research Center for the Detection of New Major Infectious Diseases, and a National Immune Testing Automation Local joint engineering laboratories, etc. At present, the company has more than 600 product registration certificates and has obtained more than 1,000 patents. In 2021, the company's operating income was 3.766 billion yuan, a year-on-year increase of 26.45%. The Antu Bioinfravitation Diagnosis Industrial Park under construction is a key construction project in Henan Province. The construction land area is more than 251 mu and the construction area is more than 720,000 square meters. After completion, it will have a production capacity of 15 billion yuan, becoming the largest in vitro diagnosis in China. One of the industrial bases. Antu Bio attaches great importance to product research and development and technological innovation, and has always regarded improving R&D and innovation capabilities as an important means to enhance the core competitiveness of the enterprise. The company attaches importance to R&D investment, and in the past three years, R&D investment has exceeded 10% of its operating income; it pays attention to team building, and technical R&D personnel account for about one-third of the company's total number; it is comparable to international advanced, and strictly manages R&D processes; it pays attention to R&D of core raw materials, The antigen and antibody self-sufficiency rate of immunodiagnostic reagent products reaches more than 77%. Antu Bio has become one of the companies in the industry with many registered documents and relatively complete product lines. Antu Bio focuses on quality and pursues excellent manufacturing. In terms of reagent production, we will introduce automated production lines to improve product automation and flow operation level, and improve the level of refined management; in terms of instrument manufacturing, we will continue to increase the intensity of refined management and advocate the craftsman spirit of continuous excellence and continuous optimization; in terms of quality management, Passed GMP, ISO9001 and ISO13485 certifications, strictly manage quality assessment, and continuously promote quality improvement. While Antu Bio focuses on independent innovation and excellent manufacturing, it also pays attention to global resource integration. Through the integration of R&D and innovation resources, and even industry advanced products, medical laboratories can provide richer products. Antu Bio takes "user first, create value" as its service concept, adheres to user-centeredness, continuously improves service standards and capabilities, and provides professional, timely and thoughtful technical services to users across the country. While providing product and technical services to users, it also provides quality control services and overall services to medical laboratories. Antu Bio's marketing network covers the whole country, and customer-oriented academic and technical promotion activities are the marketing characteristics of Antu Bio. In terms of international marketing, the company's products have been sold to Europe, Asia, the Middle East, South America, Africa and other regions.
Zhengzhou Antu Bioengineering Co., Ltd.
Zhengzhou Antu Bioengineering Co., Ltd. (hereinafter referred to as "Antu Biotechnology", stock code 603658) was founded in 1998. It focuses on the research, manufacturing, integration and services of in vitro diagnostic reagents and instruments. Its products cover immunity, microbial, biochemistry, and molecular , coagulation and other testing fields can provide medical laboratories with complete product solutions and overall services. The company was listed on September 1, 2016. It is an in vitro diagnostic research and development and manufacturing enterprise listed on the main board of the Shanghai Stock Exchange. It has been approved as a National Enterprise Technology Center, a National Engineering Research Center for the Detection of New Major Infectious Diseases, and a National Immune Testing Automation Local joint engineering laboratories, etc. At present, the company has more than 600 product registration certificates and has obtained more than 1,000 patents. In 2021, the company's operating income was 3.766 billion yuan, a year-on-year increase of 26.45%. The Antu Bioinfravitation Diagnosis Industrial Park under construction is a key construction project in Henan Province. The construction land area is more than 251 mu and the construction area is more than 720,000 square meters. After completion, it will have a production capacity of 15 billion yuan, becoming the largest in vitro diagnosis in China. One of the industrial bases. Antu Bio attaches great importance to product research and development and technological innovation, and has always regarded improving R&D and innovation capabilities as an important means to enhance the core competitiveness of the enterprise. The company attaches importance to R&D investment, and in the past three years, R&D investment has exceeded 10% of its operating income; it pays attention to team building, and technical R&D personnel account for about one-third of the company's total number; it is comparable to international advanced, and strictly manages R&D processes; it pays attention to R&D of core raw materials, The antigen and antibody self-sufficiency rate of immunodiagnostic reagent products reaches more than 77%. Antu Bio has become one of the companies in the industry with many registered documents and relatively complete product lines. Antu Bio focuses on quality and pursues excellent manufacturing. In terms of reagent production, we will introduce automated production lines to improve product automation and flow operation level, and improve the level of refined management; in terms of instrument manufacturing, we will continue to increase the intensity of refined management and advocate the craftsman spirit of continuous excellence and continuous optimization; in terms of quality management, Passed GMP, ISO9001 and ISO13485 certifications, strictly manage quality assessment, and continuously promote quality improvement. While Antu Bio focuses on independent innovation and excellent manufacturing, it also pays attention to global resource integration. Through the integration of R&D and innovation resources, and even industry advanced products, medical laboratories can provide richer products. Antu Bio takes "user first, create value" as its service concept, adheres to user-centeredness, continuously improves service standards and capabilities, and provides professional, timely and thoughtful technical services to users across the country. While providing product and technical services to users, it also provides quality control services and overall services to medical laboratories. Antu Bio's marketing network covers the whole country, and customer-oriented academic and technical promotion activities are the marketing characteristics of Antu Bio. In terms of international marketing, the company's products have been sold to Europe, Asia, the Middle East, South America, Africa and other regions.
Guilin Urit Medical Electronic Co., Ltd.
Guilin Youlit Electronics Group Co., Ltd. is a domestic manufacturer, supplier and service provider of medical diagnostic products. Forge ahead for thirty years and focus on testing for health. Ulit has keenly grasped the development trend of medical technology innovation and development, based on the needs of clinical medical diagnosis, and has developed eight series of products including hemorrhage cell analysis, urine analysis, and biochemical analysis. Today, Ulit has developed into a large health and medical technology group integrating R&D, production, sales and services. Its entire business is sold in more than 180 countries and regions around the world, and has been used in more than 200,000 medical institutions around the world for billions of people. Bring health and care to become one of the brands of clinical diagnostic equipment selection.
Guilin Urit Medical Electronic Co., Ltd.
Guilin Youlit Electronics Group Co., Ltd. is a domestic manufacturer, supplier and service provider of medical diagnostic products. Forge ahead for thirty years and focus on testing for health. Ulit has keenly grasped the development trend of medical technology innovation and development, based on the needs of clinical medical diagnosis, and has developed eight series of products including hemorrhage cell analysis, urine analysis, and biochemical analysis. Today, Ulit has developed into a large health and medical technology group integrating R&D, production, sales and services. Its entire business is sold in more than 180 countries and regions around the world, and has been used in more than 200,000 medical institutions around the world for billions of people. Bring health and care to become one of the brands of clinical diagnostic equipment selection.
Molecular Devices (Shanghai) Co., Ltd.
Molecular Devices was founded in Silicon Valley, USA in the 1980s, and has multiple representative offices and subsidiaries around the world. In 2005, Molecular Devices established a China Representative Office in Shanghai, joined the Danaher Group, a global innovator of science and technology in 2010, and officially established a business company in 2011: Meigu Molecular Instruments (Shanghai) Co., Ltd. Nowadays, Megumomolecules and IDT Eddite, Beckman Coulter Life Sciences, Aibocai, Aigell-Finome, Leica Microscope, Pall and other companies are affiliated to the Danaher Group Life Science Platform Operating the company. As a representative brand of high-throughput instrumentation equipment in the world, Molecular Devices is known in the industry for its continuous innovation, rapid and efficient, high-performance products and complete after-sales service. Molecular Devices has been committed to providing customers with innovative bioanalytical solutions in protein and cell biology in life science research, pharmaceutical and biotherapeutic development. Product line covers microplate reader, GxP compliance software, plate washing machine, high-connotation cell imaging system, cloning screening system, high-throughput real-time fluorescence detection and analysis system, microarray scanner, patch clamp and detection kit wait.
Molecular Devices (Shanghai) Co., Ltd.
Molecular Devices was founded in Silicon Valley, USA in the 1980s, and has multiple representative offices and subsidiaries around the world. In 2005, Molecular Devices established a China Representative Office in Shanghai, joined the Danaher Group, a global innovator of science and technology in 2010, and officially established a business company in 2011: Meigu Molecular Instruments (Shanghai) Co., Ltd. Nowadays, Megumomolecules and IDT Eddite, Beckman Coulter Life Sciences, Aibocai, Aigell-Finome, Leica Microscope, Pall and other companies are affiliated to the Danaher Group Life Science Platform Operating the company. As a representative brand of high-throughput instrumentation equipment in the world, Molecular Devices is known in the industry for its continuous innovation, rapid and efficient, high-performance products and complete after-sales service. Molecular Devices has been committed to providing customers with innovative bioanalytical solutions in protein and cell biology in life science research, pharmaceutical and biotherapeutic development. Product line covers microplate reader, GxP compliance software, plate washing machine, high-connotation cell imaging system, cloning screening system, high-throughput real-time fluorescence detection and analysis system, microarray scanner, patch clamp and detection kit wait.
Reify BioMed (Shanghai) Co., Ltd.
Revvity is a brand new brand established by the split of the former PerkinElmer Life Sciences and Diagnostics business. It is committed to developing technologies and solutions across the disease field, providing health science solutions, cutting-edge technologies and professional services, and its business covers scientific research and exploration. , development, diagnosis and treatment, the entire end-to-end process of development, diagnosis and treatment, providing diversified services to customers such as pharmaceutical and biotechnology, diagnostic laboratories, academia and government agencies.
Reify BioMed (Shanghai) Co., Ltd.
Revvity is a brand new brand established by the split of the former PerkinElmer Life Sciences and Diagnostics business. It is committed to developing technologies and solutions across the disease field, providing health science solutions, cutting-edge technologies and professional services, and its business covers scientific research and exploration. , development, diagnosis and treatment, the entire end-to-end process of development, diagnosis and treatment, providing diversified services to customers such as pharmaceutical and biotechnology, diagnostic laboratories, academia and government agencies.
Guangzhou Jinke Chian Technology Co., Ltd.
The history of BMG began in 1990 when physicist Dr. Bella Gullas founded BMG LABTECH in Offenburg, Germany. Starting from one person, BMG LABTECH has become a global manufacturing company. From beginning to end, BMG LABTECH focuses on helping other companies design solutions in the fields of microplate reading and processing. In the first three years of BMG's establishment, it was affected by the company's strategic positioning. At the shareholders' meeting, more shareholders joined in, including Dr. Thomas Räbiger, who leads the company today. Our team quickly realized that we should develop our own products and become the "microplate reader company" on the market. In 1993, BMG LABTECH received funding for the development of a fluorescence detection device. This grant is the first shot to a successful future. In the same year, BMG LABTECH launched FLUOstar, the second fluorescence-based microplate reader on the market. The development and launch of FLUOstar has made BMG LABTECH a pioneer in the field of fluorescence polarization detection. For more than 30 years, unique innovative technologies have been developed to defend their technological leadership in the field. BMG is driven by its desire to provide scientists around the world with the best research instruments. Today, BMG LABTECH provides a wide range of dedicated and multi-mode microplate readers for life science applications and high-throughput screening. BMG has been in this business for more than 30 years, maintaining very close contact with customers and has carried out extensive cooperation with major customers.
Guangzhou Jinke Chian Technology Co., Ltd.
The history of BMG began in 1990 when physicist Dr. Bella Gullas founded BMG LABTECH in Offenburg, Germany. Starting from one person, BMG LABTECH has become a global manufacturing company. From beginning to end, BMG LABTECH focuses on helping other companies design solutions in the fields of microplate reading and processing. In the first three years of BMG's establishment, it was affected by the company's strategic positioning. At the shareholders' meeting, more shareholders joined in, including Dr. Thomas Räbiger, who leads the company today. Our team quickly realized that we should develop our own products and become the "microplate reader company" on the market. In 1993, BMG LABTECH received funding for the development of a fluorescence detection device. This grant is the first shot to a successful future. In the same year, BMG LABTECH launched FLUOstar, the second fluorescence-based microplate reader on the market. The development and launch of FLUOstar has made BMG LABTECH a pioneer in the field of fluorescence polarization detection. For more than 30 years, unique innovative technologies have been developed to defend their technological leadership in the field. BMG is driven by its desire to provide scientists around the world with the best research instruments. Today, BMG LABTECH provides a wide range of dedicated and multi-mode microplate readers for life science applications and high-throughput screening. BMG has been in this business for more than 30 years, maintaining very close contact with customers and has carried out extensive cooperation with major customers.
Hangzhou Allsheng Instruments Co., Ltd.
Hangzhou Aosheng Instrument Co., Ltd. was established on January 17, 2006. It is a national high-tech enterprise integrating R&D, production and sales. It is the support unit of the high-tech enterprise research and development center of Zhejiang Aosheng Biosample Preprocessing Platform. . Aosheng has a high-quality R&D team led by a doctor, and invests 10% of the sales each year for R&D. After 17 years of research and technical precipitation, it has built a biological sample nucleic acid protein purification technology platform, an automated workstation technology platform and bioabsorbing light. Fluorescence and luminescence detection technology platform. In the future, Aosheng will be committed to automation solutions in the field of biotechnology to achieve comprehensive automation from sample preparation to result data analysis.
Hangzhou Allsheng Instruments Co., Ltd.
Hangzhou Aosheng Instrument Co., Ltd. was established on January 17, 2006. It is a national high-tech enterprise integrating R&D, production and sales. It is the support unit of the high-tech enterprise research and development center of Zhejiang Aosheng Biosample Preprocessing Platform. . Aosheng has a high-quality R&D team led by a doctor, and invests 10% of the sales each year for R&D. After 17 years of research and technical precipitation, it has built a biological sample nucleic acid protein purification technology platform, an automated workstation technology platform and bioabsorbing light. Fluorescence and luminescence detection technology platform. In the future, Aosheng will be committed to automation solutions in the field of biotechnology to achieve comprehensive automation from sample preparation to result data analysis.
Promega provides innovative solutions for life science research, including microplate readers, assays, and reagents for molecular biology, genomics, and cell biology.
Promega Corporation
Promega provides innovative solutions for life science research, including microplate readers, assays, and reagents for molecular biology, genomics, and cell biology.
EnSpire is a multi-mode microplate reader from PerkinElmer, designed for a variety of applications including fluorescence, luminescence, and absorbance measurements.
PerkinElmer, Inc.
EnSpire is a multi-mode microplate reader from PerkinElmer, designed for a variety of applications including fluorescence, luminescence, and absorbance measurements.
BioTek is a global leader in the development, manufacture, and sale of life science instrumentation, including microplate readers, washers, and imaging systems.
BioTek Instruments, Inc.
BioTek is a global leader in the development, manufacture, and sale of life science instrumentation, including microplate readers, washers, and imaging systems.
Beckman Coulter, a Danaher company, offers innovative solutions for biomedical testing, including microplate readers, flow cytometers, and automation systems.
Beckman Coulter, Inc.
Beckman Coulter, a Danaher company, offers innovative solutions for biomedical testing, including microplate readers, flow cytometers, and automation systems.
Agilent Technologies, Inc.
Agilent Technologies specializes in life sciences, diagnostics, and applied chemical markets, providing analytical instruments and software for research and development.
Agilent Technologies, Inc.
Agilent Technologies specializes in life sciences, diagnostics, and applied chemical markets, providing analytical instruments and software for research and development.
Roche Diagnostics Products (Shanghai) Co., Ltd.
Roche Diagnostics is committed to developing and providing innovative, cost-effective, timely and reliable diagnostic systems and solutions from early detection, prevention to diagnosis and monitoring of diseases, thereby helping medical staff improve patients' treatment effects and improve people's quality of life. Reduce social medical costs. Roche Group has two business areas: diagnostics and pharmaceuticals. This combination allows Roche Diagnostics to apply ground-breaking disease knowledge to develop innovative products, discover and monitor diseases, and guide the choice of treatment options. In August 2000, Luoche Diagnostic Products (Shanghai) Co., Ltd. was established as a wholly foreign-owned company in Shanghai Waigaoqiao Free Trade Zone to carry out business in mainland China. Since its establishment, the company's business has been growing and its scale has continued to grow. It is one of the leaders in the in vitro diagnostic market in China. To date, the company has more than 2,800 employees, distributed in 77 cities across the country. The company is headquartered in Shanghai and has established branches in Beijing, Guangzhou, Chengdu, Nanjing, Wuhan, Xi'an, Hangzhou, Jinan and Urumqi. The company's product sales and service network is spread all over the country. With its first-class technical products and perfect services, it has won a wide market and reputation. Roche Diagnostics has made a firm commitment to the Chinese market and will contribute to China's medical and healthcare cause and the improvement of people's quality of life by improving testing efficiency and medical value.
Roche Diagnostics Products (Shanghai) Co., Ltd.
Roche Diagnostics is committed to developing and providing innovative, cost-effective, timely and reliable diagnostic systems and solutions from early detection, prevention to diagnosis and monitoring of diseases, thereby helping medical staff improve patients' treatment effects and improve people's quality of life. Reduce social medical costs. Roche Group has two business areas: diagnostics and pharmaceuticals. This combination allows Roche Diagnostics to apply ground-breaking disease knowledge to develop innovative products, discover and monitor diseases, and guide the choice of treatment options. In August 2000, Luoche Diagnostic Products (Shanghai) Co., Ltd. was established as a wholly foreign-owned company in Shanghai Waigaoqiao Free Trade Zone to carry out business in mainland China. Since its establishment, the company's business has been growing and its scale has continued to grow. It is one of the leaders in the in vitro diagnostic market in China. To date, the company has more than 2,800 employees, distributed in 77 cities across the country. The company is headquartered in Shanghai and has established branches in Beijing, Guangzhou, Chengdu, Nanjing, Wuhan, Xi'an, Hangzhou, Jinan and Urumqi. The company's product sales and service network is spread all over the country. With its first-class technical products and perfect services, it has won a wide market and reputation. Roche Diagnostics has made a firm commitment to the Chinese market and will contribute to China's medical and healthcare cause and the improvement of people's quality of life by improving testing efficiency and medical value.
Cytation is a series of multi-mode microplate readers from BioTek, combining microplate reading and imaging capabilities for comprehensive research solutions.
BioTek Instruments, Inc.
Cytation is a series of multi-mode microplate readers from BioTek, combining microplate reading and imaging capabilities for comprehensive research solutions.
Eppendorf (Shanghai) International Trading Co., Ltd.
Eppendorf is a cutting-edge life sciences company focusing on the research and development and sale of lab instruments, consumables and services for liquid processing, sample processing and cell processing. Main products include pipettes, automatic pipetting systems, dispensers, centrifuges, mixing instruments, spectrophotometers and DNA amplification instruments, as well as ultra-low temperature refrigerators, fermentation tanks, bioreactors, CO2 incubators, and bioshaking beds and cell microscopy operating systems, consumables include high-performance high-quality products such as pipettes, centrifuge tubes, PCR plates, microplates and disposable bioreactor tanks. Eppendorf's products are widely used in scientific research and commercial R&D laboratories, such as pharmaceutical and biotechnology, chemistry and food industries. In addition, the company's products are also widely used by clinical and environmental analysis laboratories, forensics and industrial users in process analysis, production and quality testing. Founded in 1945, Eppendorf is headquartered in Hamburg, Germany and currently employs about 4,500 people worldwide. The company has subsidiaries in 28 countries and has distributors in relevant and important market areas around the world.
Eppendorf (Shanghai) International Trading Co., Ltd.
Eppendorf is a cutting-edge life sciences company focusing on the research and development and sale of lab instruments, consumables and services for liquid processing, sample processing and cell processing. Main products include pipettes, automatic pipetting systems, dispensers, centrifuges, mixing instruments, spectrophotometers and DNA amplification instruments, as well as ultra-low temperature refrigerators, fermentation tanks, bioreactors, CO2 incubators, and bioshaking beds and cell microscopy operating systems, consumables include high-performance high-quality products such as pipettes, centrifuge tubes, PCR plates, microplates and disposable bioreactor tanks. Eppendorf's products are widely used in scientific research and commercial R&D laboratories, such as pharmaceutical and biotechnology, chemistry and food industries. In addition, the company's products are also widely used by clinical and environmental analysis laboratories, forensics and industrial users in process analysis, production and quality testing. Founded in 1945, Eppendorf is headquartered in Hamburg, Germany and currently employs about 4,500 people worldwide. The company has subsidiaries in 28 countries and has distributors in relevant and important market areas around the world.
PerkinElmer Enterprise Management (Shanghai) Co., Ltd.
PerkinElmer is the world's largest manufacturer of analytical instruments. The company is composed of scientists dedicated to product development and development, marketing personnel and business professionals who provide technical support and sales services to customers. Since its establishment in 1937, it has continuously provided users with the world's advanced instruments, technologies and services in the field of analytical chemistry; it has produced a variety of chemical analytical instruments, including: atomic absorption spectrometer, plasma emission spectrometer, plasma mass spectrometer, gas chromatography- Mass spectrometer, engineering gas chromatograph, portable and micro gas chromatograph, liquid chromatograph and other analytical instruments, as well as GC-FTIR, TGA-FTIR, HGA-ICP-MS, GC-MS and other combined instruments; generally used in the environment , food and consumer products, etc., are mainly committed to ensuring human health and environmental safety. PerkinElmer has a long history and brilliant achievements in the analytical instrument industry, especially in high-throughput drug screening, fully automatic liquid processing and sample preparation. Starting from January 1, 2009, the company's business will focus more on two strategic priorities - human health and environmental health. PerkinElmer entered China in 1978 and has established a strong technical and after-sales service team in business fields such as environmental health, food safety, life sciences, laboratory services, overall information solutions of big data, diagnosis, etc. over the past 40 years. In order to further meet the needs of Chinese customers, PerkinElmer has continuously expanded its scale and has set up customer experience centers (CKCs for short), global software R&D teams and global application development centers in office buildings in Shanghai, Guangzhou, Beijing and Chengdu. Taicang has set up a production and R&D base just to get closer to Chinese users.
PerkinElmer Enterprise Management (Shanghai) Co., Ltd.
PerkinElmer is the world's largest manufacturer of analytical instruments. The company is composed of scientists dedicated to product development and development, marketing personnel and business professionals who provide technical support and sales services to customers. Since its establishment in 1937, it has continuously provided users with the world's advanced instruments, technologies and services in the field of analytical chemistry; it has produced a variety of chemical analytical instruments, including: atomic absorption spectrometer, plasma emission spectrometer, plasma mass spectrometer, gas chromatography- Mass spectrometer, engineering gas chromatograph, portable and micro gas chromatograph, liquid chromatograph and other analytical instruments, as well as GC-FTIR, TGA-FTIR, HGA-ICP-MS, GC-MS and other combined instruments; generally used in the environment , food and consumer products, etc., are mainly committed to ensuring human health and environmental safety. PerkinElmer has a long history and brilliant achievements in the analytical instrument industry, especially in high-throughput drug screening, fully automatic liquid processing and sample preparation. Starting from January 1, 2009, the company's business will focus more on two strategic priorities - human health and environmental health. PerkinElmer entered China in 1978 and has established a strong technical and after-sales service team in business fields such as environmental health, food safety, life sciences, laboratory services, overall information solutions of big data, diagnosis, etc. over the past 40 years. In order to further meet the needs of Chinese customers, PerkinElmer has continuously expanded its scale and has set up customer experience centers (CKCs for short), global software R&D teams and global application development centers in office buildings in Shanghai, Guangzhou, Beijing and Chengdu. Taicang has set up a production and R&D base just to get closer to Chinese users.
